Device Trial Radar · NCT07266389
Clinical Efficacy Evaluation of Supraglottic Airway Device SafeLM™ in Paediatric Population
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Dec 2, 2025
Primary completion
Nov 30, 2026
Study completion Dec 30, 2026
Sponsor
- Lead sponsor
- National University of MalaysiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Malaya
- First posted
- Dec 5, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 0 years, up to 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this interventional study is to evaluate the clinical efficacy of SafeLM™, a video laryngeal mask airway device in paediatric population. The main questions it aims to answer are: 1. To determine the success rate, ease of device insertion, time for insertion, and how well the device seals the airway by measuring the oropharyngeal leak pressure (OPLP) of SafeLM™. 2. To determine the incidence of complication associated with SafeLM™ usage. 3. To study the association of glottic view with success rate and rate of complication. Participants perioperative clinical data will be collected for data analysis.
Conditions
- Anesthesia
- Supraglottic Airway Efficiency
- Paediatric Airway Management
Interventions
SafeLM™ as the airway management device during general anaesthesiaDevice
Appropriate size of SafeLM™ is selected for participants as manufacturer recommendation. Size 2 is for participants with body weight of 10-20 kg, recommended cuff volume to be inflated is 10 to 15 ml. Size 2.5 is for participants with body weight of 20-30 kg, recommended cuff volume to be inflated is 14 to 21 ml. Size 3 is for participants with body weight of 30-50 kg, recommended cuff volume to be inflated is 20 to 30 ml. Size 4 is for participants with body weight of 50-70 kg, recommended cuff volume to be inflated is 30 to 45 ml Size 5 is for participants with body weight of 70-100 kg, recommended cuff volume to be inflated is 40 to 60 ml. Under general anaesthesia, the device is held by the anaesthesiologist at the distal end while advancing the laryngeal mask by sliding down the palatopharyngeal curve along the midline in the mouth until the end of the mask reach the hypopharynx cavity and resistance is met, under direct real-time visualisation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success rate of device placement in percentageTime frame: Perioperative
- Oropharyngeal leak pressure (OPLP) in cmH2OTime frame: From the time of successful device placement confirmation to the time of determination of OPLP before commencement of surgery
- Glottic exposure gradesTime frame: At the time of completion of device placement procedure, when the distal end of the cuff reaches the hypopharyngeal cavity, resistance is met, and the cuff is inflated with appropriate volume of air as per manufacturer recommendation.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Malaya
Kuala Lumpur, Malaysia · Recruiting
Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.